These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 2727573

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Depression and Parkinson's Disease: study of a series of 135 Parkinson's patients].
    Anguenot A, Loll PY, Neau JP, Ingrand P, Gil R.
    Can J Neurol Sci; 2002 May; 29(2):139-46. PubMed ID: 12038469
    [Abstract] [Full Text] [Related]

  • 24. Cognitive impairment patterns in Parkinson's disease with visual hallucinations.
    Ozer F, Meral H, Hanoglu L, Ozturk O, Aydemir T, Cetin S, Atmaca B, Tiras R.
    J Clin Neurosci; 2007 Aug; 14(8):742-6. PubMed ID: 17544275
    [Abstract] [Full Text] [Related]

  • 25. Rivastigmine in Parkinson's disease dementia.
    Chitnis S, Rao J.
    Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):941-55. PubMed ID: 19619073
    [Abstract] [Full Text] [Related]

  • 26. [Dementia and Parkinson's disease: biochemical and anatomo-clinical correlation].
    Dubois B, Hauw JJ, Ruberg M, Serdaru M, Javoy-Agid F, Agid Y.
    Rev Neurol (Paris); 1985 Aug; 141(3):184-93. PubMed ID: 4001706
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Cognitive dysfunctions in mild Parkinson's disease dementia: comparison with patients having mild Alzheimer's disease and normal controls.
    Song IU, Kim JS, Yoo JY, Song HJ, Lee KS.
    Eur Neurol; 2008 Aug; 59(1-2):49-54. PubMed ID: 17917458
    [Abstract] [Full Text] [Related]

  • 30. Cholinergic-dependent cognitive deficits in Parkinson's disease.
    Dubois B, Danzé F, Pillon B, Cusimano G, Lhermitte F, Agid Y.
    Ann Neurol; 1987 Jul; 22(1):26-30. PubMed ID: 3631918
    [Abstract] [Full Text] [Related]

  • 31. Current management of the cognitive dysfunction in Parkinson's disease: how far have we come?
    Vale S.
    Exp Biol Med (Maywood); 2008 Aug; 233(8):941-51. PubMed ID: 18535172
    [Abstract] [Full Text] [Related]

  • 32. [Prevalence of mental disorders in persons with Parkinson's disease].
    de Rijk C, Bijl RV.
    Ned Tijdschr Geneeskd; 1998 Jan 03; 142(1):27-31. PubMed ID: 9556986
    [Abstract] [Full Text] [Related]

  • 33. Therapy of behavioral disorders in Parkinson's disease.
    Valldeoriola F, Molinuevo J.
    Biomed Pharmacother; 1999 Apr 03; 53(3):149-53. PubMed ID: 10349504
    [Abstract] [Full Text] [Related]

  • 34. [Cognitive deterioration in Parkinson's disease].
    Perea-Bartolomé MV.
    Rev Neurol; 1999 Apr 03; 32(12):1182-7. PubMed ID: 11562851
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Cognitive and behavioral disorders in Parkinson disease].
    Pascual-Leone A, Press D.
    Rev Neurol; 1999 Apr 03; 29(2):152-7. PubMed ID: 10528330
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Neuropsychiatric and cognitive symptoms in Parkinson disease].
    Aarsland D, Pedersen KF, Ehrt U, Bronnick K, Gjerstad MD, Larsen JP.
    Tidsskr Nor Laegeforen; 2008 Sep 25; 128(18):2072-6. PubMed ID: 18846124
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.